Waterstone Pharmaceuticals is an international pharmaceutical company with its main operations in China. The company is focused in discovery,

development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases and cancer. With venture capital investments from internally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing.

On top of the forty marked drugs in China, the company has also built a rich pipeline including five Drug Master Files with U.S. FDA , two candidates that have completed two phase II/III clinical tries with cFDA, and several novel early stage oncology candidates.

Waterstone is an international bio-pharmaceutical company committed to the discovery, development and commercilization of therapeutics for significant unmet medical needs

Mobile Scan´╝îLearn more
About
Company Profile
Management Team
Board of Directors
Vision & Mission
Corporate History
Pipeline
Liver Diseases
Oncology
ANDA
Products
Marketing
Sales Network
Other Drug Products
API (DMFs)
Febuxostat
Gensicilovir Sodium
Lansoprizoe
Investors
Burrill & Company
Acorn Campus Ventures
CID Group
Orbimed
News
Company News
Media Reports
Publications
Contacts
Location & massage
Career